Jake Mintz and Jordan Shusterman dig into what is going wrong with the Yankees, who was selected as an All-Star starter and ...
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
Key Takeaways Eli Lilly received FDA approval for a drug to help treat Alzheimer's on Tuesday after studies showed it could ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The Food and Drug Administration (FDA) on Tuesday approved donanemab, Eli Lilly’s monoclonal antibody drug for early-stage ...